Arcutis Biotherapeutics, Inc. Common Stock, Par Value $0.0001 per Share Underwriting AgreementUnderwriting Agreement • August 5th, 2022 • Arcutis Biotherapeutics, Inc. • Pharmaceutical preparations • New York
Arcutis Biotherapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 7,500,000 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock,” and such shares the “Firm Shares”) and, at the election of the Underwriters, up to 1,125,000 additional shares (the “Optional Shares”) of Common Stock (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
